Charlestin, V.; Tan, E.; Arias-Matus, C.E.; Wu, J.; Miranda-Vergara, M.C.; Lee, M.; Wang, M.; Nannapaneni, D.T.; Tennakoon, P.; Blagg, B.S.J.;
et al. Evaluation of the Mammalian Aquaporin Inhibitors Auphen and Z433927330 in Treating Breast Cancer. Cancers 2024, 16, 2714.
https://doi.org/10.3390/cancers16152714
AMA Style
Charlestin V, Tan E, Arias-Matus CE, Wu J, Miranda-Vergara MC, Lee M, Wang M, Nannapaneni DT, Tennakoon P, Blagg BSJ,
et al. Evaluation of the Mammalian Aquaporin Inhibitors Auphen and Z433927330 in Treating Breast Cancer. Cancers. 2024; 16(15):2714.
https://doi.org/10.3390/cancers16152714
Chicago/Turabian Style
Charlestin, Verodia, Elijah Tan, Carlos Eduardo Arias-Matus, Junmin Wu, Maria Cristina Miranda-Vergara, Mijoon Lee, Man Wang, Dharma T. Nannapaneni, Parinda Tennakoon, Brian S. J. Blagg,
and et al. 2024. "Evaluation of the Mammalian Aquaporin Inhibitors Auphen and Z433927330 in Treating Breast Cancer" Cancers 16, no. 15: 2714.
https://doi.org/10.3390/cancers16152714
APA Style
Charlestin, V., Tan, E., Arias-Matus, C. E., Wu, J., Miranda-Vergara, M. C., Lee, M., Wang, M., Nannapaneni, D. T., Tennakoon, P., Blagg, B. S. J., Ashfeld, B. L., Kaliney, W., Li, J., & Littlepage, L. E.
(2024). Evaluation of the Mammalian Aquaporin Inhibitors Auphen and Z433927330 in Treating Breast Cancer. Cancers, 16(15), 2714.
https://doi.org/10.3390/cancers16152714